WorldCare Clinical Commences Phase III Clinical Trial for Treatment of Soft Tissue Sarcoma
Leading Imaging CRO Combines Experience and Innovation in Soft Tissue Cancers Clinical Trials
Boston, MA, May 28, 2017 -- WorldCare Clinical (WCC), a leading provider of imaging services in Oncology clinical trials, today announced that it had commenced imaging services on a Phase III international clinical trial to assess a new treatment for soft tissue sarcoma.
Soft tissue sarcoma is a rare cancer that occurs in the body's soft
tissue (muscles, fat, blood vessels, tendons, fibrous tissues and synovial
tissues). About 40 percent of the diagnoses occur in the legs, usually at or
above the knee. Soft tissue sarcomas can metastasize to other organs of the
body. Each year, approximately 3,900
people in the United States die from the disease.
In the current clinical trial, WCC is working with sites in the United
States, Europe, and Asia to acquire MR images of the knee area. These MR images are then assessed using
state-of-the-art analysis software by board-certified radiologists from Harvard
Hospitals who specialize in sarcoma diagnosis.
WCC's approach to rare cancers is consistent with its approach to other
rare diseases such as beta thalassemia and adrenoleukodystrophy. "We leverage our large network of clinical
affiliations to access subspecialty experts whose acumen allow us to maximize
the accuracy of the assessment. This is
complemented by our experienced scientific and operational team, ensuring
high-quality results and a smooth trial," stated Aaron Timm, CEO of WorldCare
Clinical is a global imaging CRO that employs scientific expertise, innovative
technology, and operational excellence to maximize the precision and accuracy
of a blinded independent central review of Phase I – IV clinical trial data.
The company has worked with thousands of sites in more than 60 countries. WCC's
robust technology platform processes over 250 million images annually (CT, MRI,
X-Ray, Echo, US, PET). Originally founded in 1992 by the Massachusetts General
Hospital (MGH) Department of Radiology, WorldCare Clinical today is a Proscan
Imaging company. With over 400 employees worldwide supporting
WorldCare Clinical's mission, the company continues to maintain a strategic
relationship with the Harvard Hospital System as well as other leading academic
For more information on WCC's services,
please visit our website at www.wcclinical.com